Athanasios Rogdakis
Athanasios Rogdakis has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Anastasios C. Datsis
Messolonghi General Hospital
2 shared publications - Archodoula Vaxevanidou
Department of Anesthesiology, Messologi General Hospital, Messologi, Greece
2 shared publications - Georgios Zacharis
Department of General Surgery, St. Andrew’s General Hospital, Patras, Greece
2 shared publications - John Spiliotis
METAXA Cancer Hospital
2 shared publications - Aphrodite Fotiadou
Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; Department of General, Visceral and Transplantation Surgery, University Hospital of Heidelberg, Heidelberg, Germany
1 shared publication - Demetrios Karnabatidis
Department of Interventional Radiology, University of Patras Medical School, Rion, Patras 26500, Greece
1 shared publication
Latest Publications
- Open Access
- 16 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 742
The Role of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal GIST-Induced Sarcomatosis (GISTosis)
Background: The introduction of tyrosine kinase inhibitors has revolutionised the treatment of gastrointestinal stromal tumours (GISTs), yet the role of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal GISTosis remains controversial. Methods: A retrospective analysis was conducted on patients with peritoneal GISTosis who underwent CRS plus HIPEC in an 18-year period. We analysed the clinicopathological characteristics and evaluated the perioperative and long-term outcomes based on the extent of disease (peritoneal cancer index, PCI), the resection (completeness of cytoreduction score) and the IM-administration. The survival factors were also analysed and the Kaplan–Meier estimator to model and estimate overall (OS) and progression-free survival (PFS). The median follow-up period was 72 months (range, 12–146). Results: A total of 25 patients (M:F = 15:10) with a median age of 57 years (range, 32–69) underwent CRS with HIPEC for peritoneal GIST metastases, detected either synchronously (n = 11) or metachronously (n = 14). The media PCI score was 9 (range, 4–20) and complete cytoreduction was achieved in 80%. Grade III complications were observed in two patients, whereas there was no postoperative mortality. Neoadjuvant imatinib-mesylate (IM) therapy was administered in 60% of patients who detected with metachronous metastases (n = 8/14), whereas adjuvant IM therapy was administered in 19 of 25 patients. Median OS was 62 months (95% CI = 22.8–101.2). Median OS and DFS for patients with PCI scores ≤ 10 were significantly longer compared to those with PCI scores > 10 (p = 0.009 and p = 0.024, respectively). Patients with CC scores of 0–1 had a significantly longer OS compared to those with CC scores of 2 (p = 0.005) and 3 (p = 0.002) and longer PFS compared to those with CC scores of 3 (p = 0.005). The need for imatinib did not significantly impact OS (p = 0.240) or PFS (p = 0.243). Conclusions: CRS combined with HIPEC shows promising results in peritoneal GISTosis, especially in patients with lower PCI and CC scores. Until larger studies validate its safety and efficacy, it should be primarily performed in expert hands in specialised peritoneal surface oncology centres.
- 16 January 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 742
Open AccessThe Role of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal GIST-Induced Sarcomatosis (GISTosis)
Background: The introduction of tyrosine kinase inhibitors has revolutionised the treatment of gastrointestinal stromal tumours (GISTs), yet the role of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal GISTosis remains controversial. Methods: A retrospective analysis was conducted on patients with peritoneal GISTosis who underwent CRS plus HIPEC in an 18-year period. We analysed the clinicopathological characteristics and evaluated the perioperative and long-term outcomes based on the extent of disease (peritoneal cancer index, PCI), the resection (completeness of cytoreduction score) and the IM-administration. The survival factors were also analysed and the Kaplan–Meier estimator to model and estimate overall (OS) and progression-free survival (PFS). The median follow-up period was 72 months (range, 12–146). Results: A total of 25 patients (M:F = 15:10) with a median age of 57 years (range, 32–69) underwent CRS with HIPEC for peritoneal GIST metastases, detected either synchronously (n = 11) or metachronously (n = 14). The media PCI score was 9 (range, 4–20) and complete cytoreduction was achieved in 80%. Grade III complications were observed in two patients, whereas there was no postoperative mortality. Neoadjuvant imatinib-mesylate (IM) therapy was administered in 60% of patients who detected with metachronous metastases (n = 8/14), whereas adjuvant IM therapy was administered in 19 of 25 patients. Median OS was 62 months (95% CI = 22.8–101.2). Median OS and DFS for patients with PCI scores ≤ 10 were significantly longer compared to those with PCI scores > 10 (p = 0.009 and p = 0.024, respectively). Patients with CC scores of 0–1 had a significantly longer OS compared to those with CC scores of 2 (p = 0.005) and 3 (p = 0.002) and longer PFS compared to those with CC scores of 3 (p = 0.005). The need for imatinib did not significantly impact OS (p = 0.240) or PFS (p = 0.243). Conclusions: CRS combined with HIPEC shows promising results in peritoneal GISTosis, especially in patients with lower PCI and CC scores. Until larger studies validate its safety and efficacy, it should be primarily performed in expert hands in specialised peritoneal surface oncology centres.
- 1 June 2011
- Published by Springer Nature in Hellenic Journal of Surgery
- Vol. 83 (3) , 166-169
Spontaneous chylous peritonitis presenting as acute surgical abdomen
- 1 June 2011
- Published by Springer Nature in Hellenic Journal of Surgery
- Vol. 83 (3) , 166-169
Spontaneous chylous peritonitis presenting as acute surgical abdomen
- Open Access
- 1 January 2009
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 4 (1) , 12
Wound dehiscence: is still a problem in the 21th century: a retrospective study
The aim of this study was to evaluate the risk factors of wound dehiscence and determine which of them can be reverted.
- 1 January 2009
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 4 (1) , 12
Open AccessWound dehiscence: is still a problem in the 21th century: a retrospective study
The aim of this study was to evaluate the risk factors of wound dehiscence and determine which of them can be reverted.
- Open Access
- 1 January 2009
- Published by Springer Nature in Cases Journal
- Vol. 2 (1) , 6339
Acute cholangitis due to afferent loop syndrome after a Whipple procedure: a case report
Patients with resection of stomach and especially with Billroth II reconstruction (gastro jejunal anastomosis), are more likely to develop afferent loop syndrome which is a rare complication. When the afferent part is obstructed, biliary and pancreatic secretions accumulate and cause the distention of this part. In the case of a complete obstruction (rare), there is a high risk developing necrosis and perforation. This complication has been reported once in the literature.
- 1 January 2009
- Published by Springer Nature in Cases Journal
- Vol. 2 (1) , 6339
Open AccessAcute cholangitis due to afferent loop syndrome after a Whipple procedure: a case report
Patients with resection of stomach and especially with Billroth II reconstruction (gastro jejunal anastomosis), are more likely to develop afferent loop syndrome which is a rare complication. When the afferent part is obstructed, biliary and pancreatic secretions accumulate and cause the distention of this part. In the case of a complete obstruction (rare), there is a high risk developing necrosis and perforation. This complication has been reported once in the literature.